Advertisement
Syngene International
Healthcare
05 July, 2023
GIC-backed Syngene inks $88-mn deal to buy Stelis Biopharma's unit
Syngene International Ltd, a drug research company backed by Singapore sovereign wealth fund GIC, is set to acquire Stelis Biopharma’s manufacturing unit in Bengaluru for ......
Premium
Finance
25 February, 2019
Taking five- to seven-year horizon for India healthcare bets: Temasek's R Venkatesh
Singapore state investment firm Temasek Holdings has been an active investor in India’s healthcare and pharmaceutical sectors. Its latest investment ......
Premium
Healthcare
21 September, 2016
Robust IPO market bodes well for healthcare sector: IVFA's Siddharth Dhondiyal
The healthcare sector will continue to remain a top priority for sector-agnostic private equity firm India Value Fund Advisors (IVFA), ......
Advertisement
Recommended for you
Advertisement